Beyond biologics: fungal polysaccharides as dual-function materials for nanomedicine.

IF 3.9
Nanomedicine (London, England) Pub Date : 2025-09-01 Epub Date: 2025-07-29 DOI:10.1080/17435889.2025.2540775
Mengting Wu, Wenjun Zhang, Hui Song, Yang Hu, Wenlan Li
{"title":"Beyond biologics: fungal polysaccharides as dual-function materials for nanomedicine.","authors":"Mengting Wu, Wenjun Zhang, Hui Song, Yang Hu, Wenlan Li","doi":"10.1080/17435889.2025.2540775","DOIUrl":null,"url":null,"abstract":"<p><p>Fungal polysaccharides exhibit a unique dual role in nano-delivery systems as both bioactive agents and functional carrier materials. Their intrinsic biocompatibility, biodegradability, and immunomodulatory properties enable applications in cancer therapy, immunoregulation, inflammation control, and nutrient delivery. As active components, their therapeutic efficacy is often limited by poor solubility and low bioavailability - issues that can be overcome via nanotechnology strategies such as encapsulation in nanoparticles, nanogels, and nanoemulsions. When used as carriers, fungal polysaccharides offer high drug-loading capacity, tunable surface chemistry, and inherent immune-targeting potential. They enable controlled release, improved stability, and synergistic effects in combination therapies and vaccine adjuvants. However, challenges remain in structural standardization, reproducibility, and understanding structure - activity relationships - particularly regarding higher-order conformations and their biological implications. This review summarizes recent advances in fungal polysaccharide-based nano-delivery systems, emphasizing their structural attributes, formulation strategies, and multifunctional therapeutic roles. It also outlines future directions, including smart carrier design, stimuli-responsiveness, and scalable production. A deeper understanding of their structural biology will guide the rational development of safe and efficient polysaccharide-based nanoplatforms for precision medicine.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":" ","pages":"2275-2289"},"PeriodicalIF":3.9000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17435889.2025.2540775","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/29 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Fungal polysaccharides exhibit a unique dual role in nano-delivery systems as both bioactive agents and functional carrier materials. Their intrinsic biocompatibility, biodegradability, and immunomodulatory properties enable applications in cancer therapy, immunoregulation, inflammation control, and nutrient delivery. As active components, their therapeutic efficacy is often limited by poor solubility and low bioavailability - issues that can be overcome via nanotechnology strategies such as encapsulation in nanoparticles, nanogels, and nanoemulsions. When used as carriers, fungal polysaccharides offer high drug-loading capacity, tunable surface chemistry, and inherent immune-targeting potential. They enable controlled release, improved stability, and synergistic effects in combination therapies and vaccine adjuvants. However, challenges remain in structural standardization, reproducibility, and understanding structure - activity relationships - particularly regarding higher-order conformations and their biological implications. This review summarizes recent advances in fungal polysaccharide-based nano-delivery systems, emphasizing their structural attributes, formulation strategies, and multifunctional therapeutic roles. It also outlines future directions, including smart carrier design, stimuli-responsiveness, and scalable production. A deeper understanding of their structural biology will guide the rational development of safe and efficient polysaccharide-based nanoplatforms for precision medicine.

超越生物制剂:真菌多糖作为纳米药物的双重功能材料。
真菌多糖在纳米递送系统中表现出独特的双重作用,既是生物活性剂又是功能性载体材料。其内在的生物相容性、可生物降解性和免疫调节特性使其在癌症治疗、免疫调节、炎症控制和营养输送方面的应用成为可能。作为活性成分,它们的治疗效果往往受到溶解度差和生物利用度低的限制——这些问题可以通过纳米技术策略,如纳米颗粒、纳米凝胶和纳米乳液的封装来克服。当用作载体时,真菌多糖具有高载药能力、可调节的表面化学和固有的免疫靶向潜力。它们能够在联合疗法和疫苗佐剂中控制释放、提高稳定性和协同效应。然而,在结构标准化、可重复性和对结构-活性关系的理解方面仍然存在挑战,特别是在高阶构象及其生物学意义方面。本文综述了基于真菌多糖的纳米递送系统的最新进展,重点介绍了它们的结构特性、配方策略和多功能治疗作用。它还概述了未来的发展方向,包括智能载波设计、刺激响应和可扩展生产。对其结构生物学的深入了解将指导安全高效的精准医学纳米多糖平台的合理开发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信